J, K., S, Y., H, I., S, O., ZX, Y., C, L., . . . J, M. (2023). ADP-ribose-acceptor hydrolase 2 ( Arh2 ) deficiency results in cardiac dysfunction, tumorigenesis, inflammation, and decreased survival. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2023.02.07.527494
Chicago Style (17th ed.) CitationJ, Kato, et al. "ADP-ribose-acceptor Hydrolase 2 ( Arh2 ) Deficiency Results in Cardiac Dysfunction, Tumorigenesis, Inflammation, and Decreased Survival." BioRxiv : The Preprint Server for Biology 2023. https://doi.org/10.1101/2023.02.07.527494.
MLA (9th ed.) CitationJ, Kato, et al. "ADP-ribose-acceptor Hydrolase 2 ( Arh2 ) Deficiency Results in Cardiac Dysfunction, Tumorigenesis, Inflammation, and Decreased Survival." BioRxiv : The Preprint Server for Biology, 2023, https://doi.org/10.1101/2023.02.07.527494.